|
Top 20 Cancer Therapy Brands ForecastPublished by: Datamonitor Published: Oct. 2, 2009 - 125 Pages Table of Contents
AbstractIntroductionThe cancer therapies market offers a high level of commercial reward to a handful of companies including Roche, Sanofi-Aventis, AstraZeneca, Novartis and Eli Lilly. Cancer therapy sales totaled over $38 billion in the seven major pharmaceutical markets in 2008, growing at a CAGR of 17.4% between 2005 and 2008. Reasons to Purchase
Get Full Details About This Report >> |
|
|||
|
About MarketResearch.com
|
||||